Evaluation of ceftobiprole medocaril against Enterococcus faecalis in a mouse peritonitis model
dc.contributor.author | Arias, Cesar A. | |
dc.contributor.author | Singh, Kavindra V. | |
dc.contributor.author | Panesso, Diana | |
dc.contributor.author | Murray, Barbara E. | |
dc.contributor.orcid | Panesso, Diana [0000-0002-4049-9702] | |
dc.date.accessioned | 2020-12-03T19:31:04Z | |
dc.date.available | 2020-12-03T19:31:04Z | |
dc.date.issued | 2007 | |
dc.description.abstractenglish | Ceftobiprole is a novel broad-spectrum cephalosporin with good in vitro activity against methicillin-resistant Staphylococcus aureus and Enterococcus faecalis. The objective of this study was to assess the in vivo activity of ceftobiprole against four strains of E. faecalis, including β-lactamase- producing (Bla+) and vancomycin-resistant strains. Mice were infected intraperitoneally with strains of E. faecalis: (i) the Bla+ strain HH22; (ii) two vancomycin-resistant strains (TX2484 and V583); and (iii) OG1RF (a laboratory strain), using 10 × the LD50 for each strain. Ceftobiprole doses of 25, 12.5 and 6.25 mg/kg (single doses) and ampicillin 50, 25, 12.5 and 6.25 mg/kg (single and double doses) were administered subcutaneously immediately after bacterial challenge and mice were monitored for 96 h. All four E. faecalis had ceftobiprole MICs ≤0.5 mg/L. Despite being susceptible in vitro at the standard inoculum, ampicillin (single and double doses) did not protect mice against intraperitoneal challenge with Bla+ E. faecalis HH22, with a 50% protective dose (PD50) of >100 mg/kg, whereas ceftobiprole was protective (PD50 of 2 mg/kg). Ceftobiprole PD50s for vancomycin-resistant isolates TX2484 and V583 were 7.7 and 5.2 mg/kg, respectively, similar to those of single dose ampicillin (12.5 and 16.4 mg/kg, respectively). For OG1RF, both ampicillin and ceftobiprole protected all mice at doses of 25 and 12.5 mg/kg, respectively, with a PD50 of 4.2 and 8 mg/kg for ceftobiprole and ampicillin, respectively. Ceftobiprole had comparable in vivo activity to that of ampicillin against vancomycin-resistant and ampicillin-susceptible strains of E. faecalis in the mouse peritonitis model. Ceftobiprole was superior in vivo to ampicillin against the Bla+ strain HH22. Our data support the further study of ceftobiprole as a therapeutic agent in humans infected with E. faecalis. | eng |
dc.format.mimetype | application/pdf | |
dc.identifier.doi | https://doi.org/10.1093/jac/dkm237 | |
dc.identifier.instname | instname:Universidad El Bosque | spa |
dc.identifier.issn | 1460-2091 | |
dc.identifier.reponame | reponame:Repositorio Institucional Universidad El Bosque | spa |
dc.identifier.repourl | https://repositorio.unbosque.edu.co | |
dc.identifier.uri | https://hdl.handle.net/20.500.12495/5169 | |
dc.language.iso | eng | |
dc.publisher.journal | Journal of Antimicrobial Chemotherapy | spa |
dc.relation.ispartofseries | Journal of Antimicrobial Chemotherapy, 1460-2091, Vol. 60, Nro. 3, 2007 p. 594-598 | spa |
dc.relation.uri | https://academic.oup.com/jac/article/60/3/594/734011 | |
dc.rights.accessrights | https://purl.org/coar/access_right/c_abf2 | |
dc.rights.accessrights | info:eu-repo/semantics/openAccess | |
dc.rights.accessrights | Acceso abierto | |
dc.rights.creativecommons | 2007 | |
dc.rights.local | Acceso abierto | spa |
dc.subject.keywords | Enterococci | spa |
dc.subject.keywords | Cephalosporins | spa |
dc.subject.keywords | Animal model | spa |
dc.title | Evaluation of ceftobiprole medocaril against Enterococcus faecalis in a mouse peritonitis model | spa |
dc.title.translated | Evaluation of ceftobiprole medocaril against Enterococcus faecalis in a mouse peritonitis model | spa |
dc.type.coar | https://purl.org/coar/resource_type/c_6501 | |
dc.type.driver | info:eu-repo/semantics/article | |
dc.type.hasversion | info:eu-repo/semantics/publishedVersion | |
dc.type.local | Artículo de revista |
Archivos
Bloque original
1 - 1 de 1
No hay miniatura disponible
- Nombre:
- Arias_Cesar_A._2007.pdf
- Tamaño:
- 167.14 KB
- Formato:
- Adobe Portable Document Format
- Descripción:
Bloque de licencias
1 - 1 de 1
No hay miniatura disponible
- Nombre:
- license.txt
- Tamaño:
- 1.71 KB
- Formato:
- Item-specific license agreed upon to submission
- Descripción: